David D. Chang

Insider Reports History

Location
South San Francisco, CA
Signature
/s/Earl Douglas, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David D. Chang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 5.28M $10.3M $1.96 14 Mar 2025 Direct
Allogene Therapeutics, Inc. President and CEO, Director Common Stock 1.2M $2.35M $1.96 14 Mar 2025 Indirect
Allogene Therapeutics, Inc. President and CEO, Director Stock Option (Right to buy) 1.95M 24 Jan 2025 Direct

Insider Reports Filed by David D. Chang

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALLO Allogene Therapeutics, Inc. 14 Mar 2025 1 -$91.5K 4 President and CEO, Director 18 Mar 2025, 17:30
ALLO Allogene Therapeutics, Inc. 03 Feb 2025 1 -$77.3K 4 President and CEO, Director 05 Feb 2025, 16:13
ALLO Allogene Therapeutics, Inc. 24 Jan 2025 2 $0 4 President and CEO, Director 28 Jan 2025, 20:10
ALLO Allogene Therapeutics, Inc. 16 May 2024 1 $1M 4 President and CEO, Director 20 May 2024, 18:01
ALLO Allogene Therapeutics, Inc. 14 Mar 2024 1 -$231K 4 President and CEO, Director 18 Mar 2024, 20:10
ALLO Allogene Therapeutics, Inc. 25 Jan 2024 2 $0 4 President and CEO, Director 31 Jan 2024, 17:42
ALLO Allogene Therapeutics, Inc. 22 Mar 2023 2 $0 4 President and CEO, Director 24 Mar 2023, 20:13
ALLO Allogene Therapeutics, Inc. 14 Mar 2023 1 -$124K 4 President and CEO, Director 16 Mar 2023, 17:32
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 1 $0 4 President and CEO, Director 25 Mar 2022, 17:51
ALLO Allogene Therapeutics, Inc. 15 Mar 2022 1 -$181K 4 President and CEO, Director 17 Mar 2022, 17:59
ALLO Allogene Therapeutics, Inc. 24 May 2021 2 $499K 4 President and CEO, Director 26 May 2021, 08:00